5Antonio A, Nicola M. New approaches to analyzing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers [J ]. Pharmacoepidemiology and Drug Safety, 2002 ( 11 ) : 721-726.
6中华人民共和国卫生部.卫生政务通报(2007年5月)[J/OL].www.moh.gov.cn.
7Dubois RW, Chawla AJ, Neslusan CA, et al. Explaining drug spending trends: does perception mateh reality[J ]. Health Affairs, 2000(19) :231-239.
8Morgan SG. Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan[J]. Health Services Research, 2002(37) : 1243-1266.
9Berndt ER. Pharmaceuticals in U.S. health care: determinants of quantity and prices [J]. Journal of Economic Perspectives, 2002(16): 45-66.
